Invivyd, Inc. Files 8-K on Financials and Operations
Ticker: IVVD · Form: 8-K · Filed: May 15, 2025 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | 8-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations, company-update
TL;DR
Invivyd dropped an 8-K detailing financials and other events. Check it out.
AI Summary
Invivyd, Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition, as well as other events. The filing also includes financial statements and exhibits. The company was formerly known as Adagio Therapeutics, Inc. and changed its name on November 12, 2020.
Why It Matters
This 8-K filing provides investors with crucial updates on Invivyd's financial health and operational events, which can influence investment decisions.
Risk Assessment
Risk Level: low — This filing is a standard 8-K reporting routine financial and operational information, not indicating any immediate or unusual risks.
Key Players & Entities
- Invivyd, Inc. (company) — Registrant
- Adagio Therapeutics, Inc. (company) — Former company name
- May 15, 2025 (date) — Date of report
- November 12, 2020 (date) — Date of name change
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.
What 'Other Events' are reported in this 8-K?
The filing lists 'Other Events' as a category but does not specify what those events are in the provided text.
When did Invivyd, Inc. change its name from Adagio Therapeutics, Inc.?
Invivyd, Inc. changed its name from Adagio Therapeutics, Inc. on November 12, 2020.
What is Invivyd, Inc.'s principal executive office address?
Invivyd, Inc.'s principal executive offices are located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.
What is the SIC code for Invivyd, Inc.?
The Standard Industrial Classification (SIC) code for Invivyd, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding Invivyd, Inc. (IVVD).